HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Xu Selected Research

COVID-19

12/2023Willingness to receive and recommend hypothetical mpox vaccination and associated factors in Chinese adults: a community-based survey in Shenzhen, China.
6/2020[Application of tracheotomy in the treatment of severe cases of COVID-19].
6/2020Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.
4/2020[Application of tracheotomy in the treatment of severe cases of COVID-19].
1/2020Impact of the COVID-19 outbreak on adjuvant chemotherapy for patients with stage II or III colon cancer: experiences from a multicentre clinical trial in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Xu Research Topics

Disease

126Neoplasms (Cancer)
03/2024 - 01/2000
32Neoplasm Metastasis (Metastasis)
12/2023 - 09/2001
28Infections
03/2024 - 03/2000
25Carcinoma (Carcinomatosis)
11/2022 - 05/2000
19Breast Neoplasms (Breast Cancer)
05/2022 - 03/2000
19Carcinogenesis
07/2021 - 10/2000
15Type 2 Diabetes Mellitus (MODY)
09/2019 - 02/2000
14Inflammation (Inflammations)
08/2023 - 01/2000
13Hepatocellular Carcinoma (Hepatoma)
11/2023 - 06/2000
13Hypoxia (Hypoxemia)
01/2021 - 01/2001
13Stroke (Strokes)
01/2020 - 11/2010
13Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 05/2000
12Stomach Neoplasms (Stomach Cancer)
12/2023 - 09/2001
12Aneurysm (Aneurysms)
03/2020 - 12/2005
11Allergic Rhinitis
09/2023 - 06/2009
11Fibrosis (Cirrhosis)
07/2022 - 04/2000
11Prostatic Neoplasms (Prostate Cancer)
07/2018 - 03/2006
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 04/2000
10Multiple Myeloma
02/2024 - 06/2016
10Melanoma (Melanoma, Malignant)
11/2023 - 10/2001
10Pathologic Constriction (Stenosis)
01/2022 - 09/2009
10Leukemia
01/2017 - 07/2000
9Infarction (Infarctions)
10/2022 - 06/2000
9Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 02/2013
9Necrosis
08/2018 - 01/2001
8Asthma (Bronchial Asthma)
04/2024 - 01/2000
8Hypertension (High Blood Pressure)
05/2023 - 10/2000
8Insulin Resistance
04/2023 - 11/2009
8Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 10/2004
8Ischemia
06/2001 - 02/2000
7Colorectal Neoplasms (Colorectal Cancer)
05/2023 - 04/2011
7Body Weight (Weight, Body)
04/2023 - 12/2001
7Pain (Aches)
10/2022 - 07/2001
7Diabetes Mellitus
02/2022 - 11/2010
7Lung Neoplasms (Lung Cancer)
02/2020 - 06/2000
7Myocardial Infarction
01/2020 - 02/2000
6Hemorrhage
03/2024 - 07/2013
6Atrophy
01/2022 - 05/2000
6Obesity
12/2021 - 09/2002
6Tuberculosis (Tuberculoses)
02/2021 - 12/2005
6Adenocarcinoma
12/2019 - 12/2000
5COVID-19
12/2023 - 01/2020
5Liver Neoplasms (Liver Cancer)
11/2023 - 01/2015
5Cicatrix (Scar)
10/2023 - 05/2000
5Wounds and Injuries (Trauma)
09/2023 - 11/2011
5Pneumonia (Pneumonitis)
08/2023 - 07/2017
5Heart Failure
07/2022 - 03/2000
5Lymphatic Metastasis
01/2021 - 12/2001
5Ischemic Stroke
11/2020 - 11/2008
5Atherosclerosis
11/2020 - 03/2000
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2017 - 06/2000
5Esophageal Neoplasms (Esophageal Cancer)
01/2016 - 09/2001
4Chronic Obstructive Pulmonary Disease (COPD)
05/2024 - 01/2012
4Dyspnea (Shortness of Breath)
10/2023 - 05/2001

Drug/Important Bio-Agent (IBA)

61Proteins (Proteins, Gene)FDA Link
04/2023 - 03/2000
31Biomarkers (Surrogate Marker)IBA
01/2024 - 04/2000
21Messenger RNA (mRNA)IBA
08/2023 - 01/2000
21DNA (Deoxyribonucleic Acid)IBA
02/2021 - 02/2000
20CytokinesIBA
06/2023 - 05/2000
18AntigensIBA
02/2021 - 02/2000
17Glucose (Dextrose)FDA LinkGeneric
02/2022 - 02/2000
13Long Noncoding RNAIBA
01/2023 - 08/2015
13MicroRNAs (MicroRNA)IBA
09/2020 - 01/2012
13VaccinesIBA
01/2020 - 01/2000
10CollagenIBA
08/2023 - 08/2000
10Insulin (Novolin)FDA Link
02/2017 - 02/2000
8C-Reactive ProteinIBA
03/2024 - 01/2011
8salicylhydroxamic acid (SHAM)IBA
06/2023 - 03/2000
8Anti-Bacterial Agents (Antibiotics)IBA
08/2022 - 07/2001
8Indicators and Reagents (Reagents)IBA
11/2020 - 05/2000
8LipidsIBA
01/2013 - 03/2000
8Complementary DNA (cDNA)IBA
09/2012 - 01/2001
7Monoclonal AntibodiesIBA
11/2023 - 04/2001
7NF-kappa B (NF-kB)IBA
08/2021 - 06/2001
7LigandsIBA
06/2019 - 05/2000
6AllergensIBA
09/2023 - 04/2016
6Hemoglobins (Hemoglobin)IBA
01/2022 - 03/2013
6Small Interfering RNA (siRNA)IBA
01/2020 - 03/2006
6Transcription Factors (Transcription Factor)IBA
01/2020 - 10/2001
6Phosphotransferases (Kinase)IBA
06/2019 - 10/2000
6EnzymesIBA
01/2015 - 04/2000
5Therapeutic UsesIBA
03/2024 - 12/2000
5Cisplatin (Platino)FDA LinkGeneric
12/2023 - 10/2012
5InterferonsIBA
11/2023 - 06/2001
5Angiotensin IIIBA
01/2018 - 04/2000
5RNA (Ribonucleic Acid)IBA
01/2018 - 06/2001
5Interferon-gamma (Interferon, gamma)IBA
11/2016 - 01/2000
5Protein Kinase CIBA
10/2001 - 10/2000
4Interleukin-6 (Interleukin 6)IBA
05/2024 - 01/2000
4Immune Checkpoint InhibitorsIBA
03/2024 - 11/2020
4AntibodiesIBA
03/2024 - 10/2001

Therapy/Procedure

60Therapeutics
01/2024 - 05/2000
14Drug Therapy (Chemotherapy)
12/2023 - 06/2000
13Immunotherapy
05/2024 - 05/2011
12Stents
03/2020 - 12/2005
10Radiotherapy
05/2023 - 06/2000
8Hematopoietic Stem Cell Transplantation
02/2023 - 06/2017
7Transplantation
10/2021 - 11/2000
6Aftercare (After-Treatment)
03/2023 - 11/2015
5Ligation
01/2023 - 05/2011